GlaxoSmithKline PLC — Remuneration Information 2018

Jan 23, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7049C

GlaxoSmithKline PLC

23 January 2018

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr B McNamara

b)

Position/status

CEO, Consumer Healthcare

c)

Initial notification/

amendment

Initial notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

American Depositary Shares ('ADSs')

ISIN: US37733W1053

b)

Nature of the transaction

The vesting of an award over 2,163 ADSs made under the GlaxoSmithKline Share Value Plan (SVP). Of the vested award, 1,066 ADSs were automatically withheld to meet tax liabilities.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
$38.346 .	2,163

d)

Aggregated information

Aggregated volume Price

n/a (single transaction)

e)

Date of the transaction

2018-01-22

f)

Place of the transaction

New York Stock Exchange (XNYS)

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEXLFLVFFLBBB